CTCs
BioSkryb Genomics, 1Cell.Ai Partner on Circulating Tumor Cell Analysis
The firms will combine BioSkryb's chemistry with 1Cell.Ai's cell isolation platform, offering services of the codeveloped assay at their respective US labs.
CityUHK, Cellomics to Develop Circulating Tumor Cell Screening Platform
Within two years, the team hopes to commercialize an assay that combines cell sorting, staining, and imaging, as well as protein and gene profiling.
Assaying both CTCs and ctDNA simultaneously offers a path to more accurate and early cancer detection and drug response monitoring.
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
OneCell Diagnostics Raises $16M in Series A Round
The precision oncology company plans to bring its OncoIndx Ikon liquid biopsy circulating tumor cell detection test to the US market.
Jun 21, 2024
Angle Raises $630K in Open Offer of Shares
Apr 24, 2024
Angle Inks Assay Development Deal with AstraZeneca
Feb 23, 2023
Oct 31, 2022
Aug 18, 2021